COVID19 – EURETINA

Video

EURETINA Session 1: Decision Making in Challenging Cases – Challenging COVID case

Presenter: Nigel Davies

Video

Symposium Session 5: Remote Monitoring Of Retinal Diseases And The Implications Of Durable, Long-Acting Therapeutics In Clinical Practice, Especially In Times Of Covid-19 – Introduction

Presenter: Francesco Bandello

Video

Symposium Session 5: Remote Monitoring Of Retinal Diseases And The Implications Of Durable, Long-Acting Therapeutics In Clinical Practice, Especially In Times Of Covid-19 – False alarms in home monitoring for macular disease

Presenter: Dawn Sim

Video

Prize Papers 5: Imaging I – Microvascular impairment in COVID-19 bilateral pneumonia 6-months follow-up assessed by optical coherence tomography angiography

Presenter: Manuel Saenz De Viteri

Video

Novartis: Managing Patients with Diabetic Macular Edema Through the Pandemic and Beyond: Discussing Ongoing Strategies – DME and COVID-19: What have we learnt?

Session with all faculty, chaired by Ramin Tadayoni

Video

EURETINA Session 16: Research Session – Retinal findings in patients with COVID-19

Presenter: Alessandro Invernizzi

Video

Video Competition – Endogenous Candida endophthalmitis in a 4-month-old female with previous Covid-19 infection

Video Competition Entry by: Ana Catalina Rodriguez

2021 Abstracts

The impact of COVID-19 pandemic on primary retinal detachments: presenting characteristics, timings and surgical decisions

Author: André Ferreira (Portugal)

Co-authors: Miguel Afonso, Nisa Silva, Angelina Meireles

2021 Abstracts

Unescorted clinic visits: practical consequences of a stressor imposed by the COVID-19 pandemic

Author: PARIS TRANOS (Greece)

Co-authors: Penelope de Politis, Despoina Vasileiou, Vasilis Vasileiades, Panos Stavrakas

2021 Abstracts

Shall we change our attitude in screening for retinopathy of prematurity during the COVID-19 pandemic?

Author: Bilge Batu Oto (Turkey)

Co-authors: Oguzhan Kilicarslan, Yesim Tok, Ahmet Mert Kuskucu, Huseyin Yetik

2021 Abstracts

The impact of COVID19 on treatment with Aflibercept in the real world – a clinical audit of people with neovascular Age Related Macular Degeneration from 21 UK hospitals

Author: Andrew Lotery (United Kingdom)

Co-authors: Paul Donachie, Romi Chabra, Shahram Kashani, Martin McKibbin, Narendra Dhingra, Peter Scanlon

2021 Abstracts

Effects of the COVID-19 pandemic on anti-vascular endothelial growth factor treatment in China

Author: Han Zhang (China)

Co-authors: Kai-Bo Yang, Hao Feng

2021 Abstracts

Decrease in intravitreal injections of anti-Vascular Endothelial Growth Factor (anti-VEGF) attendance during COVID-19 lockdown in a tertiary level hospital.

Author: Juan Marín Nieto (Spain)

Co-authors: María Victoria Segura Fernández-Noguera, Juan Yanguas Lucena

2021 Abstracts

Treatment guidance and enhancing communication when managing patients with retinal disease in the era of COVID-19

Author: Richard Gale (United Kingdom)

Co-authors: Jean-François Korobelnik, Anat Loewenstein, Paolo Lanzetta, David T. Wong, Jane Barratt, on behalf of the Vision Academy

2021 Abstracts

Efficacy of the Diabetic Eye Screening Program (DESP) and referrals to Hospital Eye Service (HES) pathway during COVID-19 pandemic.

Author: Nanayakkara Godakandage Isuru Ravihansa De Silva (United Kingdom)

Co-authors: Yasir Khan, Niaz Islam